APOE and coronary artery disorder: In addition, 4G/5G polymorphism of the PAI-1 gene may modify the inhibitor’s synthesis [11], and it has been postulated that the mutation of apolipoprotein E gene (E2/E3) is associated with coronary artery disease [12].